This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Search results
From Proteopedia
You searched for Applications
There is no page with the exact title "Applications". The search results for "Applications" are displayed below. You can create a page titled Applications (by clicking on the red link).
For more information about searching Proteopedia, see Help.
To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Image:Applications.png (118 bytes)
1: Therapeutic applications of Monoclonal Antibodies - DNA - History of the discovery and current applications (Hebrew) (22,281 bytes)
1: == History of the discovery and current applications (Hebrew) ==
Page text matches
- 1vyo (4,008 bytes)
24: ...r avidin-based life science and nanobiotechnology applications. - 2boi (5,068 bytes)
24: ... organism for biotechnological and pharmaceutical applications and allowed an ORF encoding a protein that is 60%... - 1gkl (4,980 bytes)
24: ...dition to having promising industrial and medical applications. RESULTS: We have cloned and overexpressed the fe... - 2j2i (6,982 bytes)
24: ...-reactivities that may lead to alternate clinical applications. For example, LY333'531, a PKCbeta inhibitor curr... - 4hjg (3,750 bytes)
12: ...valent "linker" for any meditope-enabled mAb with applications in multiple mAb-based technologies including diag... - 1vfn (4,985 bytes)
24: ...sign of inhibitors with potential pharmacological applications. - 1uwg (4,696 bytes)
22: ...cat) = 0.4 s(-1)), allowing for preparative scale applications. This antibody represents one of the rare example... - 1h1d (5,002 bytes)
24: ...ng inhibitor that is expected to have therapeutic applications. - 2jem (5,030 bytes)
23: ...matic biomass conversion, their role in detergent applications, and the utility of modified xyloglucans for cell... - 2jeq (5,319 bytes)
24: ...matic biomass conversion, their role in detergent applications, and the utility of modified xyloglucans for cell... - 2jen (5,494 bytes)
24: ...matic biomass conversion, their role in detergent applications, and the utility of modified xyloglucans for cell... - 2jep (5,241 bytes)
24: ...matic biomass conversion, their role in detergent applications, and the utility of modified xyloglucans for cell... - 1ol0 (3,931 bytes)
22: ...ey are nonimmunogenic, and in other biotechnology applications. We present the structure of a camelized human an... - 7e8p (4,294 bytes)
14: ...ful for future improvement of HadA's biocatalytic applications. - 7e8q (4,273 bytes)
14: ...ful for future improvement of HadA's biocatalytic applications. - 1uu4 (4,683 bytes)
24: ...ral cellulases that are of interest in industrial applications, we have solved four new crystal structures of wi... - 1uum (5,076 bytes)
24: ... drug design in different biological and clinical applications for cancer and arthritis. The first crystal struc... - 1uu5 (4,602 bytes)
24: ...ral cellulases that are of interest in industrial applications, we have solved four new crystal structures of wi... - 1uuo (5,127 bytes)
24: ... drug design in different biological and clinical applications for cancer and arthritis. The first crystal struc... - 1uu6 (4,697 bytes)
24: ...ral cellulases that are of interest in industrial applications, we have solved four new crystal structures of wi...
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
You may also try
